NR1H4 and metabolic dysfunction-associated steatotic liver disease: The authors gleaned from previous investigations that NAFLD patients have increased levels of blood bile acids, altered primary and secondary bile acid ratios, and impaired bile acid signaling pathways mediated by FXR and FGF4 in the liver (68).